Balanced news tone
News Sentiment
OPTH sentiment intelligence
Optimi Health Corp. Common Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
88/100 classification confidence.
directly relevant articles
high-authority source matches
-5.9% over one week, +0.9% over four weeks, trend inactive, and near fair-value range.
Optimi Health Makes Third Commercial Shipment of Psilocybin for Treatment-Resistant Depression to Australia
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Optimi Health Makes Third Commercial Shipment of Psilocybin for Treatment-Resistant Depression to Australia
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 15:49
- Source
- MT Newswires
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 15:13
- Source
- PR Newswire
Optimi Health Completes Third Psilocybin Export to Australia
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 13:36
- Source
- MT Newswires
Optimi Health (NASDAQ: OPTH) makes third psilocybin shipment for TRD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Stock Titan
Optimi Health Ord Shs (OPTH) Dividends & Stock Splits: Historical Payouts and Event Timeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 17:12
- Source
- TradingKey
Optimi Health Ord Shs (OPTH) Shareholder Structure: Major Shareholders & Institutional Holdings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 17:11
- Source
- TradingKey
Optimi Health Corp. (OPTH) Free Cash Flow (TTM)
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 20 Jun 2026 00:33
- Source
- Zacks Investment Research
Optimi Health Launches Microdose Psilocybin Products for Clinical Research
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 18:02
- Source
- MT Newswires
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 16:36
- Source
- PR Newswire
Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 12 Jun 2026 07:34
- Source
- Simply Wall St.
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 18:24
- Source
- CNW Group
Optimi Health Completes First Export of Psilocybin to UK
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 13:40
- Source
- MT Newswires
Optimi Health Corp. Completes First Export of Psilocybin to the UK for Phase 2 Clinical Trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Quiver Quantitative
Optimi Health (OPTH) Earnings Date and Reports 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jun 2026 07:00
- Source
- MarketBeat
What is the current Price Target and Forecast for Optimi Health Corp. (OPTH)
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 24 May 2026 10:00
- Source
- Zacks Investment Research
Optimi Health (OPTH) Stock Forecast and Price Target 2026
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 23 May 2026 02:36
- Source
- MarketBeat
Optimi Health (OPTH) Stock Chart and Price History 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 04:04
- Source
- MarketBeat
Optimi Health (OPTH) 10K Form and Latest SEC Filings 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 04:04
- Source
- MarketBeat
Optimi Health (OPTH) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 23:11
- Source
- MarketBeat
Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- TMX Newsfile
SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- The Manila Times
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 07:00
- Source
- PR Newswire
Optimi Health files for $20 million US IPO on Nasdaq By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Investing.com Nigeria
Optimi Health launches ibogaine initiative in response to Trump’s executive order
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- Mugglehead Investment Magazine
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Investing News Network
Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Mar 2026 07:00
- Source
- TMX Newsfile
OPTH IPO News - Canada-based psychedelics manufacturer Optimi Health files for a $25 million US IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Sep 2025 07:00
- Source
- renaissancecapital.com